medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2013; 12 (5)


Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid

Sánchez-García A, Ríos-Ibarra CP, Rincón-Sánchez AR, Ortiz-López R, Garza-Juárez A, Morlett-Chávez J, Martínez-Rodríguez H, Rivas-Estilla AM

Idioma: Ingles.
Referencias bibliográficas: 28
Paginas: 725-732
Archivo PDF: 319.96 Kb.


RESUMEN

sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alter M. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436-41.

  2. Drazan K. Molecular biology of hepatitis C infection. Liver Transplantation 2000; 6: 396-406.

  3. Sabahi A. Hepatitis C virus entry: the early stops in the viral replication cycle. Virology J 2009; 6: 117.

  4. Sy T, Jamal M. Epidemiology of Hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 41-6.

  5. Brass V, Moradpour D, Blum H. Molecular virology of hepatitis C virus (HCV): 2006 Update. Int J Medical Sciences 2006; 3: 29-34.

  6. Chevaliez S, Pawlotsky J. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007; 13: 2461-6.

  7. Blight K, Kolykhalov A, Rice C. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290: 1972-4.

  8. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623-6.

  9. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-3.

  10. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-6.

  11. Trujillo K, Rincón AR, Martínez H, Bosques F, Ramos J, Barrera HA, Rivas AM, et al. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase-2 signaling pathways. Hepatology 2008; 47: 1462-72.

  12. Jacobs JM, Diamond DL, Chan EY, Gritsenko MA, Qian W, Stastna M, Baas T, et al. Proteome analysis of liver cells expressing a full length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol 2005; 79: 7558-9.

  13. Castagnino J. Proteómica y sus aplicaciones en medicina humana. Acta Bioquim Clin Latinoam 2008; 42: 179-82.

  14. Hortin G, Jortani S, Ritchie J, Valdes R, Chan D. Proteomics: A new diagnostic frontier. Clinical Chemistry 2006; 52: 1218-22.

  15. Molloy M, Witzmann F. Proteomics: Technologies and applications. Briefings in functional genomics and proteomics 2001; 1: 23-9.

  16. Motonari T, Yasuhiro K, Yuuichiro Y, Norio I, Toshifusa T, Isao S, Kiwamu O, et al. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 2003; 3: 2487-93.

  17. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy Server. In: Walker JM (ed). NJ: Humana Press Inc., 2005, p 571-607.

  18. Liao CL, Lin YL, Wu BC, Tsao CH, Wang MC, Liu CI, Huang YL, et al. Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation. J Virol 2001; 75: 7828-39.

  19. Speir E, Yu ZX, Ferrans VJ, Huang ES, Epstein SE. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 1998; 83: 210-6.

  20. Primache V, Binda S, De Benedittis G, Barbi M. In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus. New Microbiol 1998; 21: 397-401.

  21. Xun M, Zhao SH, Cao CX, Song J, Shao MM, Chu YL. Proteomic analysis of Huh-7 cells harboring in Vitro-transcribed full-length hepatitis C virus 1b RNA. Act Pharmacol Sin 2008; 29: 720-7.

  22. Diamond DL, Jacobs JM, Paeper B, Proll SC, Gritsenko MA, Carithers RL, Larson AM, et al. Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatology 2007; 46: 649-57.

  23. Joyce MA, Walters KA, Lamb SE, Yeh MM, Zhu LF, Kneteman N, Doyle JS, et al. HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/ Alb-uPA mice. PLoS Pathog 2009; 5: e1000291.

  24. Fang C, Yi Z, Liu F, Lan S, Wang J, Lu H, Yang P, et al. Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon. Proteomics 2006; 6: 519-27.

  25. Hartman SE, Bertone P, Nath AK, Royce TE, Gerstein M, Weissman S, Snyder M. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 2005; 19: 2953-68.

  26. Hinze K, Wald K, Zeng H, Jeffery E, Finley J. Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J Nutr 2003; 133: 2721-7.

  27. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999; 20: 1657-66.

  28. Shirakura M, Murakami K, Ichimura T, Suzuki R, Shimoji T, Fukuda K, Abe K, et al. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 2007; 81: 1174-85.




2020     |     www.medigraphic.com